Iridex (IRIX) Total Non-Current Liabilities (2011 - 2026)
Iridex's (IRIX) quarterly Total Non-Current Liabilities came in at $23.1 million in Q2 2026, down 14.73% year-on-year from $27.1 million in Q2 2025, and down 3.1% quarter-over-quarter from $23.8 million in Q1 2026.
Iridex (IRIX) Total Non-Current Liabilities (2011 - 2026) Analysis & Trends
Iridex's Total Non-Current Liabilities history runs 16 years deep, the most recent figure standing at $23.1 million for Q2 2026.
- On a quarterly basis, Total Non-Current Liabilities fell 14.73% year-over-year to $23.1 million in Q2 2026; TTM through Apr 2026 was $23.1 million, a 14.73% decrease from a year earlier, with the FY2026 full-year figure at $23.8 million, down 10.78% from the prior year.
- Total Non-Current Liabilities retreated to $23.1 million in Q2 2026 per IRIX's latest filing, from $23.8 million in the prior quarter.
- Across five years, Total Non-Current Liabilities topped out at $27.3 million in Q1 2024 and bottomed at $22.7 million in Q3 2023.
- The 5-year median for Total Non-Current Liabilities is $25.3 million (2022), against an average of $25.4 million.
- Across the five-year window, Total Non-Current Liabilities surged 139.7% in 2022 and declined 15.3% in 2023, its largest moves.
- Year by year, Total Non-Current Liabilities stood at $25.0 million in 2022, then slipped by 1.13% to $24.8 million in 2023, then rose by 7.98% to $26.7 million in 2024, then dropped by 12.6% to $23.4 million in 2025, then fell by 1.09% to $23.1 million in 2026.
- Per Business Quant, the three latest IRIX Total Non-Current Liabilities figures stand at $23.1 million (Q2 2026), $23.8 million (Q1 2026), and $23.4 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 20.94 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 41.44 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 41.88 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 2.64 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 3.53 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 9.85 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 24.21 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 3.57 Bn |
| 10 | Iridex | 15.93 Mn | 11.33 Mn | 4.74 Mn | 23.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 4, 2026 | 23.10 Mn |
| Jan 3, 2026 | 23.84 Mn |
| Sep 27, 2025 | 23.36 Mn |
| Jun 28, 2025 | 25.22 Mn |
| Mar 29, 2025 | 27.09 Mn |
| Dec 28, 2024 | 26.72 Mn |
| Sep 28, 2024 | 27.21 Mn |
| Jun 29, 2024 | 26.70 Mn |
| Mar 30, 2024 | 27.30 Mn |
| Dec 30, 2023 | 24.75 Mn |
| Sep 30, 2023 | 22.75 Mn |
| Jul 1, 2023 | 23.46 Mn |
| Apr 1, 2023 | 24.97 Mn |
| Dec 31, 2022 | 25.03 Mn |
| Oct 1, 2022 | 26.86 Mn |
| Jul 2, 2022 | 26.19 Mn |
| Apr 2, 2022 | 26.67 Mn |
| Jan 1, 2022 | 25.36 Mn |
| Oct 2, 2021 | 25.20 Mn |
| Jul 3, 2021 | 23.62 Mn |